{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:15:22Z","timestamp":1788300922082,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ultrasound, CT and MRI"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1053\/j.sult.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:40:06Z","timestamp":1781541606000},"page":"188-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging of Adrenal and Extra-Adrenal Paraganglioma"],"prefix":"10.1053","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-8052","authenticated-orcid":false,"given":"Kedar G.","family":"Sharbidre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Itani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Mhlanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaykumar C.","family":"Morani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.sult.2026.06.003_bib1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.sult.2026.06.003_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1433582","article-title":"Pheochromocytoma: An updated scoping review from clinical presentation to management and treatment","volume":"15","author":"Saavedra","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1053\/j.sult.2026.06.003_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/endrev\/bnae001","article-title":"Imaging of pheochromocytomas and paragangliomas","volume":"45","author":"Timmers","year":"2024","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1053\/j.sult.2026.06.003_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1053\/j.sult.2026.06.003_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The North American Neuroendocrine Tumor Society Consensus Guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"13","key":"10.1053\/j.sult.2026.06.003_bib6","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1002\/cam4.6010","article-title":"Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options","volume":"12","author":"Eid","year":"2023","journal-title":"Cancer Med"},{"key":"10.1053\/j.sult.2026.06.003_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1021420","article-title":"Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology","volume":"13","author":"Constantinescu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1053\/j.sult.2026.06.003_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231207544","article-title":"Pheochromocytoma: A changing perspective and current concepts","volume":"14","author":"Kiriakopoulos","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.sult.2026.06.003_bib9","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1053\/j.sult.2026.06.003_bib10","first-page":"3151","article-title":"Current diagnostic imaging of pheochromocytomas and implications for therapeutic strategy","volume":"15","author":"Ctvrtlik","year":"2018","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1053\/j.sult.2026.06.003_bib11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2214\/AJR.12.9753","article-title":"MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?","volume":"201","author":"Northcutt","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.003_bib12","doi-asserted-by":"crossref","first-page":"bvae199","DOI":"10.1210\/jendso\/bvae199","article-title":"High diagnostic accuracy of arterial phase ct in differentiating pheochromocytoma in good\/poor washout adrenal masses","volume":"9","author":"Phadte","year":"2024","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1053\/j.sult.2026.06.003_bib13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00330-017-5076-5","article-title":"Pheochromocytoma as a frequent false-positive in adrenal washout CT: A systematic review and meta-analysis","volume":"28","author":"Woo","year":"2018","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1053\/j.sult.2026.06.003_bib14","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1007\/s00330-007-0695-x","article-title":"Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: Washout enhancement and other imaging features","volume":"17","author":"Park","year":"2007","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.003_bib15","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1053\/j.sult.2026.06.003_bib16","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00261-017-1198-0","article-title":"The light bulb sign in pheochromocytoma","volume":"42","author":"Fonseca","year":"2017","journal-title":"Abdom. Radiol. (NY)"},{"issue":"4","key":"10.1053\/j.sult.2026.06.003_bib17","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00261-022-03447-y","article-title":"The good, the bad, and the ugly: Uncommon CT appearances of pheochromocytoma","volume":"47","author":"Berry","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"8","key":"10.1053\/j.sult.2026.06.003_bib18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2967\/jnumed.120.259689","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"62","author":"Carrasquillo","year":"2021","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.sult.2026.06.003_bib19","first-page":"153","article-title":"Pheochromocytoma and paraganglioma: Imaging characteristics","volume":"12","author":"Baez","year":"2012","journal-title":"Cancer Imag"},{"issue":"2","key":"10.1053\/j.sult.2026.06.003_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2214\/AJR.12.9126","article-title":"Pheochromocytoma: The range of appearances on ultrasound, CT, MRI, and functional imaging","volume":"200","author":"Leung","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"10.1053\/j.sult.2026.06.003_bib21","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.2011-0333","article-title":"Functional imaging of SDHx-related head and neck paragangliomas: Comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy","volume":"96","author":"King","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1053\/j.sult.2026.06.003_bib22","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Taieb","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1053\/j.sult.2026.06.003_bib23","article-title":"Molecular imaging of paragangliomas and pheochromocytomas","volume":"7","author":"Burkett","year":"2025","journal-title":"Radiol Imag Cancer"},{"issue":"2B","key":"10.1053\/j.sult.2026.06.003_bib24","first-page":"1599","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis","volume":"26","author":"Van Der Horst-Schrivers","year":"2006","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1053\/j.sult.2026.06.003_bib25","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2009-1054","article-title":"6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess","volume":"94","author":"Fiebrich","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1053\/j.sult.2026.06.003_bib26","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1053\/j.sult.2026.06.003_bib27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00259-012-2087-y","article-title":"Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: A meta-analysis","volume":"39","author":"Treglia","year":"2012","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"16","key":"10.1053\/j.sult.2026.06.003_bib28","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma","volume":"25","author":"Timmers","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.sult.2026.06.003_bib29","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/0284185118764206","article-title":"(68)Ga-somatostatin receptor analogs and (18)F-FDG PET\/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: A meta-analysis","volume":"59","author":"Kan","year":"2018","journal-title":"Acta Radiol"},{"issue":"17","key":"10.1053\/j.sult.2026.06.003_bib30","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","author":"Janssen","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1053\/j.sult.2026.06.003_bib31","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","author":"Janssen","year":"2016","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"3","key":"10.1053\/j.sult.2026.06.003_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.118.211706","article-title":"Performance of (68)Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET in detection of pheochromocytoma and paraganglioma: A systematic review and metaanalysis","volume":"60","author":"Han","year":"2019","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1053\/j.sult.2026.06.003_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cen.12482","article-title":"Should every patient diagnosed with a phaeochromocytoma have a (1)(2)(3) I-MIBG scintigraphy?","volume":"81","author":"van Berkel","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1053\/j.sult.2026.06.003_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1196\/annals.1353.041","article-title":"Current trends in functional imaging of pheochromocytomas and paragangliomas","volume":"1073","author":"Shulkin","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1053\/j.sult.2026.06.003_bib35","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1530\/ERC-11-0170","article-title":"Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas","volume":"18","author":"Welander","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1053\/j.sult.2026.06.003_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1053\/j.sult.2026.06.003_bib37","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","article-title":"Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas","volume":"23","author":"Garcia-Carbonero","year":"2021","journal-title":"Clin Transl Oncol"},{"issue":"22","key":"10.1053\/j.sult.2026.06.003_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17223702","article-title":"Update on systemic therapies for metastatic\/unresectable pheochromocytomas and paragangliomas and future directions","volume":"17","author":"Ghosh","year":"2025","journal-title":"Cancers (Basel)"}],"container-title":["Seminars in Ultrasound, CT and MRI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217126000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217126000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:52:27Z","timestamp":1788299547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887217126000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0887217126000259"],"URL":"https:\/\/doi.org\/10.1053\/j.sult.2026.06.003","relation":{},"ISSN":["0887-2171"],"issn-type":[{"value":"0887-2171","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of Adrenal and Extra-Adrenal Paraganglioma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Ultrasound, CT and MRI","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.sult.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}